Medical News

RSS

AIDS 2012 could focus spotlight on efforts against HIV/AIDS in U.S., GlobalPost reports

Noting that Washington, D.C., has an adult HIV prevalence rate higher than some southern African countries that receive PEPFAR funding, GlobalPost writes that the International AIDS Conference, to be held in the U.S. for the first time in 22 years starting Sunday, has highlighted "that America is nowhere close to an AIDS-free generation at home."

21 Jul 2012

Redesign of 'outdated and unsafe' medical bags can cut MRSA risk

A new medical bag designed in the UK is set to transform treatment around the world after a study found a third of its outdated predecessors carry the MRSA bug.

21 Jul 2012

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

Janssen-Cilag International NV announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of DACOGEN (decitabine) for Injection.

21 Jul 2012

60 organizations, Archbishop Tutu call on Obama administration to create 5-year HIV strategy

Sixty organizations and Archbishop Desmond Tutu on Thursday released a "Call for a U.S. Government AIDS-Free Generation Strategic Plan" that "asks the Obama administration to put Secretary of State Hillary Clinton in charge of a task force to complete a [five-year] strategy in time to be announced by the next World AIDS Day -- Dec. 1, 2012," the Center for Global Health Policy's "Science Speaks" blog reports.

21 Jul 2012

Researchers discover reason why breast cancer cells become drug resistant

Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant.

21 Jul 2012

Reid blocks latest GOP effort to repeal health law

Senate Republicans had advanced the repeal effort as an amendment to the Bring Jobs Home Act. Meanwhile, House conservatives, who have also pressed to undo the health law, say state lawmakers now may be on the frontlines of the fight.

21 Jul 2012

RTI receives RWJF contract to create Public Health Quality Improvement Exchange

RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.

21 Jul 2012

Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC

Pfizer announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that crizotinib be granted conditional marketing authorization in the European Union (EU), for the treatment of adults with previously treated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

21 Jul 2012

South Africa making progress against HIV/AIDS, but still more effort needed, health minister says

Though South Africa has made progress against HIV/AIDS over the past few years, the country's "health minister says much more needs to be done," VOA News reports.

21 Jul 2012

Experts examine host recognition of Staphylococcus and E.coli bacteria

We are surrounded by bacteria, viruses, fungi and parasites. The fact that we nevertheless do not fall prey to infections is thanks to certain cellular sensor molecules such as toll-like receptors (TLR), which recognize the molecular structure of pathogens and intercede by ensuring an often completely unnoticeable elimination of the invaders. Their immune-activating abilities were only detected in 1998, a discovery which was awarded with the Nobel Prize

21 Jul 2012

New antibody can be used as early diagnostic tool for Parkinson's

Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.

21 Jul 2012

New WHO guidance recommends use of ARVs for HIV prevention

WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.

21 Jul 2012

Number of blind persons decline in Germany

The numbers of people in Germany who are blind or visually impaired is going down. Robert P. Finger and his co-authors present their findings in the current edition of Deutsches -rzteblatt International.

21 Jul 2012

U.S. government, World Bank launch initiatives to collect more, better data on women worldwide

"The World Bank and U.S. government on Thursday each announced major new initiatives aimed at expanding knowledge on the experience of women around the world, while acknowledging that much remains to be done on filling the global 'data gap' on women," Inter Press Service reports.

21 Jul 2012

CBT, pharmacologic interventions decrease depressive symptoms in cancer patients

Despite guidelines recommending screening for depression in cancer patients, it's been unclear whether interventions designed to treat this depression are effective. A study by the University of Colorado Cancer Center and other institutions, published in the Journal of the National Cancer Institute, changes that.

21 Jul 2012

Marshall University faculty member receives $426,000 NIH grant for lung cancer study

A Marshall University faculty member has been awarded a three-year, $426,000 grant by the National Institutes of Health (NIH) to further her lung cancer research.

21 Jul 2012

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.

21 Jul 2012

Study explores role of L. reuteri against foodborne infection

While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health.

21 Jul 2012

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

HIV forces us to deal with so much: sex, drugs, poverty, racism, homelessness, homophobia, sexism, illness and death. While our nation's response has been imperfect, we have gotten a lot right. And we are now at a pivotal moment where science has led us to imagine the possibility of an HIV-free generation.

21 Jul 2012

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

Research to Prevent Blindness (RPB) has awarded a grant of $110,000 to the Massachusetts Eye and Ear Infirmary to support research into the causes, treatment and prevention of blinding diseases. The research will be directed by Joan W. Miller, M.D., Chief of the Mass. Eye and Ear and Mass. General Hospital's Departments of Ophthalmology and Chair of the Department of Ophthalmology at Harvard Medical School.

21 Jul 2012

Medical News

AIDS 2012 could focus spotlight on efforts against HIV/AIDS in U.S., GlobalPost reports

Redesign of 'outdated and unsafe' medical bags can cut MRSA risk

Janssen-Cilag receives positive opinion from EMA CHMP for DACOGEN

60 organizations, Archbishop Tutu call on Obama administration to create 5-year HIV strategy

Researchers discover reason why breast cancer cells become drug resistant

Reid blocks latest GOP effort to repeal health law

RTI receives RWJF contract to create Public Health Quality Improvement Exchange

Pfizer receives positive opinion from EMA CHMP for crizotinib to treat ALK-positive NSCLC

South Africa making progress against HIV/AIDS, but still more effort needed, health minister says

Experts examine host recognition of Staphylococcus and E.coli bacteria

New antibody can be used as early diagnostic tool for Parkinson's

New WHO guidance recommends use of ARVs for HIV prevention

Number of blind persons decline in Germany

U.S. government, World Bank launch initiatives to collect more, better data on women worldwide

CBT, pharmacologic interventions decrease depressive symptoms in cancer patients

Marshall University faculty member receives $426,000 NIH grant for lung cancer study

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Study explores role of L. reuteri against foodborne infection

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

RPB awards $110,000 grant to Mass. Eye and Ear and HMS for research into blinding diseases

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News